Microbiology · Year 2 · from Microbiology
Case 1: Rocky Mountain Spotted Fever
Presentation
A 12-year-old boy from North Carolina is brought to the emergency department in mid-July with 4 days of high fever, severe headache, and body aches. His parents report that he was camping 10 days ago but do not recall seeing any tick bites. Today they noticed a rash that started on his wrists and ankles and is now spreading to his arms, legs, and trunk. On examination, temperature is 39.8°C, heart rate 115 bpm. The child appears ill with a petechial rash most prominent on the extremities, including palms and soles. Laboratory studies show sodium 128 mEq/L and platelets 95,000/μL.
Clinical Image
Petechial rash of Rocky Mountain spotted fever involving the palms and soles, with characteristic peripheral-to-central spread pattern.
Image Source: Lecture image - Rickettsia rickettsii infection
Questions
- What is the most likely diagnosis, and what is the causative organism?
- Why is immediate empiric treatment critical even without laboratory confirmation?
- Explain the pathophysiologic basis for the clinical findings.
- What is the appropriate treatment, even in pediatric patients?
Answers
- Diagnosis and organism: This is Rocky Mountain spotted fever (RMSF) caused by Rickettsia rickettsii, transmitted by dog ticks (Dermacentor species). Despite its name, most cases occur in the southeastern and south-central United States. The classic triad is fever, headache, and rash, with the rash characteristically beginning on the wrists and ankles (peripherally) and spreading centrally. The presentation in summer, geographic location, and rash distribution are classic.
- Critical need for empiric treatment: RMSF has a mortality rate of 20-25% if untreated, with death occurring within 8-15 days of symptom onset. Delays in treatment significantly increase mortality. Serologic confirmation (IFA antibodies) is not detectable until the second week of illness - too late to guide treatment decisions. Therefore, the diagnosis is fundamentally clinical, and empiric treatment must begin immediately upon clinical suspicion without waiting for laboratory confirmation.
- Pathophysiologic basis of findings: R. rickettsii is an obligate intracellular pathogen that targets vascular endothelial cells. The resulting vasculitis causes:
- Petechial rash: Endothelial damage leads to vascular leakage and hemorrhage
- Hyponatremia: Increased vascular permeability and third-spacing of fluids
- Thrombocytopenia: Platelet consumption from endothelial injury
- Headache: Cerebral vasculitis
- Can progress to DIC, ARDS, and multiorgan failure
- Appropriate treatment: The treatment of choice is doxycycline, regardless of patient age. While tetracyclines are generally avoided in children due to dental staining, the risk of death from untreated RMSF far outweighs the minimal risk from a short course of doxycycline. The American Academy of Pediatrics endorses doxycycline for suspected RMSF in children. Treatment should continue for at least 3 days after defervescence or minimum 5-7 days total. Chloramphenicol is an inferior alternative due to associated risks including aplastic anemia.